Recombinant monoclonal antibody to IL17RA. Ixekizumab is a humanized monoclonal antibody used in the treatment of autoimmune diseases.
Specifications
ImmunogenThe details of the immunogen for this antibody are not available.
Host Speciesundefined
DerivationHumanized
TypeIgG4 - kappa
SpecificityTested positive against native human antigen.
Species ReactivityHuman
ApplicationsSuitable for use in WB, IP, IF, FuncS, FC, Neut, ELISA and most other immunological methods.
CAS1143503-69-8
Generic NameIxekizumab
MW146.2 kDa
Related DiseasePsoriasis
Product Property